GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ClearPoint Neuro Inc (NAS:CLPT) » Definitions » E10

CLPT (ClearPoint Neuro) E10 : $-1.66 (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is ClearPoint Neuro E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

ClearPoint Neuro's adjusted earnings per share data for the three months ended in Dec. 2024 was $-0.200. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.66 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average E10 Growth Rate was 17.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of ClearPoint Neuro was 43.80% per year. The lowest was 17.10% per year. And the median was 30.45% per year.

As of today (2025-03-14), ClearPoint Neuro's current stock price is $12.80. ClearPoint Neuro's E10 for the quarter that ended in Dec. 2024 was $-1.66. ClearPoint Neuro's Shiller PE Ratio of today is .


ClearPoint Neuro E10 Historical Data

The historical data trend for ClearPoint Neuro's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ClearPoint Neuro E10 Chart

ClearPoint Neuro Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.03 -2.91 -2.41 -1.96 -1.66

ClearPoint Neuro Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.96 -2.22 -2.09 -1.80 -1.66

Competitive Comparison of ClearPoint Neuro's E10

For the Medical Devices subindustry, ClearPoint Neuro's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ClearPoint Neuro's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ClearPoint Neuro's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where ClearPoint Neuro's Shiller PE Ratio falls into.



ClearPoint Neuro E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ClearPoint Neuro's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.2/133.1571*133.1571
=-0.200

Current CPI (Dec. 2024) = 133.1571.

ClearPoint Neuro Quarterly Data

per share eps CPI Adj_EPS
201503 -2.000 99.621 -2.673
201506 -1.640 100.684 -2.169
201509 -0.130 100.392 -0.172
201512 -0.800 99.792 -1.067
201603 -0.890 100.470 -1.180
201606 -0.900 101.688 -1.179
201609 -0.920 101.861 -1.203
201612 -0.470 101.863 -0.614
201703 -0.460 102.862 -0.595
201706 -0.320 103.349 -0.412
201709 -0.140 104.136 -0.179
201712 -0.200 104.011 -0.256
201803 -0.150 105.290 -0.190
201806 -0.170 106.317 -0.213
201809 -0.130 106.507 -0.163
201812 -0.110 105.998 -0.138
201903 -0.110 107.251 -0.137
201906 -0.130 108.070 -0.160
201909 -0.080 108.329 -0.098
201912 -0.110 108.420 -0.135
202003 -0.130 108.902 -0.159
202006 -0.110 108.767 -0.135
202009 -0.090 109.815 -0.109
202012 -0.090 109.897 -0.109
202103 -0.130 111.754 -0.155
202106 -0.170 114.631 -0.197
202109 -0.180 115.734 -0.207
202112 -0.190 117.630 -0.215
202203 -0.170 121.301 -0.187
202206 -0.180 125.017 -0.192
202209 -0.150 125.227 -0.159
202212 -0.180 125.222 -0.191
202303 -0.230 127.348 -0.240
202306 -0.290 128.729 -0.300
202309 -0.200 129.860 -0.205
202312 -0.190 129.419 -0.195
202403 -0.160 131.776 -0.162
202406 -0.160 132.554 -0.161
202409 -0.180 133.029 -0.180
202412 -0.200 133.157 -0.200

Add all the adjusted EPS together and divide 10 will get our e10.


ClearPoint Neuro  (NAS:CLPT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


ClearPoint Neuro E10 Related Terms

Thank you for viewing the detailed overview of ClearPoint Neuro's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


ClearPoint Neuro Business Description

Traded in Other Exchanges
N/A
Address
120 S. Sierra Avenue, Suite 100, Solana Beach, CA, USA, 92075
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.
Executives
Lynnette C Fallon director 108 CHERRY HILL DRIVE, BEVERLY MA 01915
Linda M. Liau director 120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH CA 92075
Mazin Sabra officer: Chief Operating Officer 120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH CA 92075
Joseph Michael Burnett director, officer: CEO and President C/O MRI INTERVENTIONS, INC., 5 MUSICK, IRVINE CA 92618
L. Jeremy Stigall officer: GM, Biologics & Drug Delivery 120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH CA 92075
Danilo D'alessandro officer: Vice President, Finance 5 MUSICK, IRVINE CA 92618
Harold A Hurwitz officer: Chief Financial Officer
R John Fletcher director C/O VYANT BIO, INC., 201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD NJ 07070
Girin Pascal E R director C/O MRI INTERVENTIONS, INC., 5 MUSICK, IRVINE CA 92618
B Kristine Johnson director 366 FERNDALE RD S, WAYZATA MN 55391
Timothy T. Richards director ONE COMMERCE SQUARE, SUITE 2550, MEMPHIS TN 38103
Matthew B. Klein director C/O PTC THERAPEUTICS, INC., 100 CORPORATE COURT, SOUTH PLAINFIELD NJ 07080
Marcio Souza director C/O PTC THERAPEUTICS, INC., 100 CORPORATE COURT, SOUTH PLAINFIELD NJ 07080
Voyager Therapeutics, Inc. 10 percent owner 75 HAYDEN AVENUE, LEXINGTON MA 02421
Wendelin C Maners officer: Vice President, Marketing ONE COMMERCE SQUARE, SUITE 2550, MEMPHIS TN 38103